(Press-News.org) (Boston)—Elevated Lipoprotein(a) [Lp(a)] is an independent, genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD), with levels >50 mg/dL affecting 20–30% of the global population. Despite therapeutic limitations, interest in Lp(a) has increased, driven by its prognostic value and the emergence of targeted therapies. However, with increasing guideline-directed Lp(a) testing, clinician response to elevated concentrations, especially in the absence of guideline-based treatment indications, remains unclear.
In a new study and presentation at the American College of Cardiology, researchers found that elevated Lp(a) was associated with earlier and more frequent initiation of preventive pharmacotherapy. These response rates were modest in a low-risk, primary prevention study population.
Specifically, nearly 80% of patients with elevated Lp(a) >50 mg/dL did not initiate lipid-lowering therapy in the absence of other ASCVD risk factors. Drugs that drastically lower "bad" LDL cholesterol (PCSK9 inhibitors) and aspirin initiation was even less common, suggesting selective rather than systematic responses to elevated Lp(a). Together, these findings suggest that elevated Lp(a) appears to only occasionally influence prescribing behavior – behavior consistent with previous reports.
“While not currently a standard indication for statin therapy alone, elevated Lp(a) is increasingly used by clinicians as a "risk enhancer" to guide more aggressive, albeit often unstandardized, preventive measures,” says corresponding author Sheilah A. Bernard MD, associate professor of medicine at Boston University Chobanian & Avedisian School of Medicine.
The researchers conducted a multicenter retrospective observational cohort study evaluating initiation of preventive pharmacotherapy following Lp(a) measurement among nearly 15,000 patients at low risk for ASCVD. Within 90 days of Lp(a) measurement, lipid-lowering therapy initiation was uncommon but more frequent among patients with elevated Lp(a) compared to those with non-elevated Lp(a). PCSK9 inhibitor initiation was rare but more frequent among patients with elevated Lp(a). Similarly, aspirin initiation was uncommon but more frequent among patients with elevated Lp(a).
According to the researchers, these findings should not be interpreted as indicating that such prescribing is guideline-directed. “Current recommendations recognize Lp(a) as a risk-enhancing factor rather than as a treatment target, and no therapy is approved solely for Lp(a) elevation. Our analysis describes contemporary practice rather than appropriate management,” adds Bernard who also is a cardiologist at Boston Medical Center.
The findings also appear online in the American Journal of Preventive Cardiology.
END
Researchers find low response rate by clinicians to elevated levels of Lp(a)
2026-03-16
ELSE PRESS RELEASES FROM THIS DATE:
Jeonbuk National University researchers develop clustering-based framework for water level forecasting
2026-03-16
Reliable and scalable water level prediction is crucial in hydrology for effective water resources management, especially when considering challenges owing to climate change, urbanization, improper land use, and high-water demand. It directly impacts the availability and distribution of freshwater in rivers and reservoirs. Therefore, accurate forecasting via early warning systems is a highly useful technique for flood mitigation, agricultural irrigation, ecosystem and environmental sustainability, and numerous other applications. In this regard, physically-based hydrodynamic river models can be used. However, these tools require enormous amounts of data, making them less useful in data-scarce ...
Reduced air pollution from climate mitigation could boost crop yields and lower hunger risk
2026-03-16
Climate change threatens global food security; however, climate mitigation policies may increase hunger risk by driving competition for land through bioenergy production and afforestation. Based on simulations from six global agroeconomic models, researchers from The University of Tokyo, Ritsumeikan University, Kyoto University, National Institute for Environmental Studies, and E-Konzal Co. Ltd, together with collaborators from other countries, report that the ozone reduction benefits of climate mitigation ...
Scientists reveal a new class of molten planet
2026-03-16
UNDER EMBARGO UNTIL 10:00 GMT / 6:00 ET MONDAY 16 MARCH 2026
A study led by the University of Oxford has identified a new type of planet beyond our Solar System – one that stores large amounts of sulphur deep within a permanent ocean of magma. The findings have been published today (16 March) in Nature Astronomy.
The exoplanet (a planet that orbits a star outside the Solar System), known as L 98-59 d, orbits a small red star about 35 light-years from Earth. Recent observations from the James Webb Space Telescope ...
Plastic bottles transformed into Parkinson’s drug using bacteria
2026-03-16
A drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows.
The approach harnesses the power of bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the neurological disorder.
It is the first time a natural, biological process has been engineered to turn plastic waste into a therapeutic for a neurological disease, researchers say.
Scientists at the University of Edinburgh engineered E. coli bacteria to turn a type of plastic used widely in food and drink ...
New alliance clinical trial aims to improve outcomes in brain tumors
2026-03-16
A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, grade 3 IDH-mutant astrocytoma, a type of brain cancer. Supported in part by a grant from the National Cancer Institute, the study (Alliance A072301) will look at whether adding the oral medication vorasidenib to the standard oral chemotherapy can help keep the cancer from coming back after radiation.
People diagnosed with IDH-mutant, grade 3 astrocytoma usually receive surgery, followed by radiation and temozolomide, an oral chemotherapy pill. Temozolomide works by damaging the DNA of tumor ...
Intensive therapy approaches benefit infants and toddlers with cerebral palsy
2026-03-16
Infants and toddlers with unilateral cerebral palsy, which affects the brain’s control of muscles on one side of the body, show lasting improvements in hand and arm function when they receive early, high-dose therapy, according to a new multisite clinical trial led by Virginia Tech researchers at the Fralin Biomedical Research Institute at VTC.
The Baby CHAMP study — short for Children with Hemiparesis Arm-and-Hand Movement Project — directly compared three therapist-delivered interventions: two forms of constraint-induced movement therapy, which limit the stronger arm to encourage use of the weaker one when ...
National Poll: 1 in 3 parents fear their teen or young adult could cause a crash
2026-03-16
ANN ARBOR, Mich. – Motor vehicle crashes remain a leading cause of death for teens and young adults, yet many families may underestimate the risks close to home, suggests a new national poll.
One in three parents worry their teen or young adult driver could cause an accident, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
Yet, nearly all parents believe their child drives as well as or better than other young drivers and relatively few said they imposed consequences for their teen’s unsafe driving behaviors.
“Our report suggests a ...
New study maps cellular mechanisms driving fibrosis in Crohn's Disease
2026-03-16
As inflamed regions of the gut form scar tissue, the space within the gut lumen becomes smaller and more restricted, leading to symptoms of gut obstruction. There is currently no drug treatment available for this complication – eventually as fibrosis worsens, surgery becomes the only option.
The researchers discovered that the biggest build up of scar tissue takes place in the submucosa (a layer of tissue beneath the inner lining of the bowel) – this indicates that the submucosa could be the starting point where the scarring begins.
Inflammation, the hallmark of Crohn’s ...
Novel cancer drug delivery system improves Paclitaxel absorption
2026-03-16
Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high therapeutic efficacy. However, many of these compounds possess properties that make them difficult to handle, such as poor water solubility and large molecular weights. This leads to poor absorption in the body and difficulty in achieving sufficient therapeutic effects. Further, the drugs distribute to normal tissues, which lead to severe side effects. Fortunately, active research is underway to develop drug delivery systems (DDS) that effectively ...
New deep learning framework solves the cold-start problem
2026-03-16
Recommender systems suggest potentially relevant content by evaluating user preferences and are essential in reducing information overload. However, when users join a new online platform, recommendation systems often struggle to understand their preferences. With no prior interactions in the new environment, these ‘cold-start’ users are difficult to serve accurately. One promising solution is cross-domain recommendation (CDR), which transfers knowledge about a user’s tastes from one domain to another.
However, many existing cross-domain systems rely heavily on a user’s highly rated items while ignoring low ratings. In fact, dislikes can be just as informative ...